Cargando…

Determinants of endothelial dysfunction in patients with non-alcoholic steatohepatitis

Detalles Bibliográficos
Autores principales:	Sarli, Bahadir, Arinc, Huseyin, Baktir, Ahmet Oguz, Saglam, Hayrettin, Demirci, Erkan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Informa Healthcare 2014
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3916722/ https://www.ncbi.nlm.nih.gov/pubmed/24236751 http://dx.doi.org/10.3109/03009734.2013.852275

Ejemplares similares

Serum gamma glutamyl transferase and alanine transaminase concentrations predict endothelial dysfunction in patients with non-alcoholic steatohepatitis
por: Arinc, Huseyin, et al.
Publicado: (2013)

Non alcoholic steatohepatitis is associated with subclinical impairment in left ventricular function measured by speckle tracking echocardiography
por: Baktır, Ahmet Oğuz, et al.
Publicado: (2015)

Relationship between serum 25-hydroxyvitamin D levels and the SYNTAX score in patients with acute coronary syndrome
por: Baktır, Ahmet Oğuz, et al.
Publicado: (2017)

Heart Rate Recovery Is Impaired in Patients with Psoriasis
por: Sarli, Bahadir, et al.
Publicado: (2014)

Association of Red Blood Cell Distribution Width Levels with Severity of Coronary Artery Disease in Patients with Non-ST Elevation Myocardial Infarction
por: Sahin, Omer, et al.
Publicado: (2015)

Heart Rate Recovery Is Impaired in Patients with Psoriasis
por: Sarli, Bahadir, et al.
Publicado: (2013)

Heart Rate Recovery Is Impaired in Patients with Inflammatory Bowel Diseases
por: Sarli, Bahadir, et al.
Publicado: (2016)

Endothelial dysfunction in patients with non-alcoholic steatohepatitis
por: Onal, Ibrahim Koral
Publicado: (2014)

25-Hydroxy-vitamin D level may predict presence of coronary collaterals in patients with chronic coronary total occlusion
por: Dogan, Yasemin, et al.
Publicado: (2015)

Atrial Electromechanical Delay Is Impaired in Patients with Psoriasis
por: Calapkorur, Bekir, et al.
Publicado: (2015)

Non-alcoholic fatty liver disease may be associated with endothelial dysfunction
por: Balta, Sevket, et al.
Publicado: (2014)

Endothelial dysfunction and carotid atherosclerosis in non-alcoholic fatty liver disease
por: Dogru, Teoman, et al.
Publicado: (2014)

Combined alcoholic and non-alcoholic steatohepatitis
por: Ntandja Wandji, Line Carolle, et al.
Publicado: (2020)

Fructose and Non-Alcoholic Steatohepatitis
por: Roeb, Elke, et al.
Publicado: (2021)

Statins in Non-alcoholic Steatohepatitis
por: Torres-Peña, Jose D., et al.
Publicado: (2021)

Burden of non-alcoholic steatohepatitis among children with type 2 diabetes mellitus
por: Parlett, Lauren, et al.
Publicado: (2021)

Role of Alcohol Metabolism in Non-Alcoholic Steatohepatitis
por: Baker, Susan S., et al.
Publicado: (2010)

Letter: Association between Non-Alcoholic Steatohepatitis and Left Ventricular Diastolic Dysfunction in Type 2 Diabetes Mellitus (Diabetes Metab J 2020;44:267–76)
por: Yu, Sung Hoon
Publicado: (2020)

Liver Fibrogenesis in Non-Alcoholic Steatohepatitis
por: Bian, Zhaolian, et al.
Publicado: (2012)

Therapeutic approaches for non-alcoholic steatohepatitis
por: Van Gaal, Luc F., et al.
Publicado: (2021)

Endothelial dysfunction in nonalcoholic steatohepatitis with low cardiac disease risk
por: Al-hamoudi, Waleed, et al.
Publicado: (2020)

Placental extract ameliorates non-alcoholic steatohepatitis (NASH) by exerting protective effects on endothelial cells
por: Yamauchi, Akihiro, et al.
Publicado: (2017)

Expansion of macrophage and liver sinusoidal endothelial cell subpopulations during non-alcoholic steatohepatitis progression
por: Shen, Zhenyang, et al.
Publicado: (2023)

The endothelial dysfunction blocker CU06-1004 ameliorates choline-deficient L-amino acid diet-induced non-alcoholic steatohepatitis in mice
por: Bae, Cho-Rong, et al.
Publicado: (2020)

Alcoholic and non-alcoholic steatohepatitis: global perspective and emerging science
por: Brar, Gurmehr, et al.
Publicado: (2019)

Immunological Mechanisms in the Pathophysiology of Non-Alcoholic Steatohepatitis
por: Vonghia, Luisa, et al.
Publicado: (2013)

Non-Alcoholic Steatohepatitis: Pathogenesis and Clinical Management
por: Salomone, Federico, et al.
Publicado: (2015)

Conophylline inhibits non-alcoholic steatohepatitis in mice
por: Nakade, Yukiomi, et al.
Publicado: (2017)

Non-alcoholic Steatohepatitis Pathogenesis, Diagnosis, and Treatment
por: Zhu, Bo, et al.
Publicado: (2021)

Presence and Implications of Sarcopenia in Non-alcoholic Steatohepatitis
por: Habig, Gregory, et al.
Publicado: (2021)

Non-alcoholic steatohepatitis and risk of hepatocellular carcinoma
por: Rios, Rafael S., et al.
Publicado: (2021)

Mechanisms of ductular reaction in non-alcoholic steatohepatitis
por: Chen, Yue, et al.
Publicado: (2022)

Lipotoxicity as the Leading Cause of Non-Alcoholic Steatohepatitis
por: Branković, Marija, et al.
Publicado: (2022)

Incidental finding of non-alcoholic steatohepatitis-cirrhosis
por: Adrian, Therese, et al.
Publicado: (2022)

Left ventricular diastolic dysfunction in liver transplantation: a stronger association with non-alcoholic steatohepatitis
por: Marella, Hemnishil K., et al.
Publicado: (2020)

Correction: The endothelial dysfunction blocker CU06-1004 ameliorates choline-deficient L-amino acid diet-induced non-alcoholic steatohepatitis in mice
por: Bae, Cho-Rong, et al.
Publicado: (2021)

Role of ciliary dysfunction in a new model of obesity and non-alcoholic steatohepatitis: the foz/foz mice
por: Poekes, Laurence, et al.
Publicado: (2014)

Association between Non-Alcoholic Steatohepatitis and Left Ventricular Diastolic Dysfunction in Type 2 Diabetes Mellitus
por: Lee, Hokyou, et al.
Publicado: (2020)

Dietary Long-Chain Fatty Acids Accelerate Metabolic Dysfunction in Guinea Pigs with Non-Alcoholic Steatohepatitis
por: Pedersen, Kamilla, et al.
Publicado: (2023)

Comparisons between non-alcoholic steatohepatitis and alcohol-related hepatocellular carcinoma
por: Kumar, Rahul, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_r26q3orn967t9r454b6aqhnd10